Latest news and press releases about Firefly Neuroscience, Inc. (AIFF): earnings reports, analyst upgrades/downgrades, product launches, partnerships and regulatory filings. Stay updated on every market-moving event.
Based in Toronto, Canada, Firefly Neuroscience, Inc. is a medical technology and artificial intelligence firm specializing in developing neuroscientific solutions. The company's primary goal is to enhance patient outcomes for individuals affected by mental illnesses and neurological disorders.
Price
| Price | $0.93 |
| Market Cap | $14M |
| Exchange | NASDAQ |
| Country | US |
Valuation Ratios
| Price / Book | 1.29 |
| EV / EBITDA | -0.45 |
| Dividend Yield | 0.00% |
Profitability
| Return on Equity | -260.34% |
| Return on Invested Capital | -112.37% |
| Return on Assets | -189.77% |
| Gross Margin | 44.58% |
| Operating Margin | -494.16% |
| Net Margin | -506.23% |
Related companies: ANY · ARBE · CNTM · CXAI · MNDO · NTCL · NXPL
Explore sector: Technology · Software - Application
More sections of AIFF: Overview · Financials · Valuation · Statistics · Estimates · Technical · Ownership · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks